QA: iBio Inc. in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001420720_2020_iBio_Inc.pdf

Logs

Graph

Absolute values for 0001420720, iBio Inc.

  xvar xval
0 AssetsCurrent 4,808,000
1 IntangibleAssetsNetIncludingGoodwill 1,374,000
2 PropertyPlantAndEquipmentNet 24,380,000
3 remainder_Assets 24,000
4 LiabilitiesCurrent 3,458,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 24,671,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,332,000
9 ResearchAndDevelopmentExpense 5,474,000
10 remainder_Expenses 0
11 remainder_Revenues 2,018,000
12 remainder_NetIncome -1,809,000
13 remainder_ComprehensiveNetIncome -1,000
  yvar yval
0 Assets 30,586,000
1 Liabilities 28,129,000
2 Expenses 17,806,000
3 Revenues 2,018,000
4 StockholdersEquity 2,457,000
5 NetIncome -17,597,000
6 ComprehensiveNetIncome -17,597,500
7 BaseVar 40,174,500
8 EconomicCapitalRatio -0.455

Edgar->Model Mapping

Feature Distribution

Change over Time